MCID: HLL004
MIFTS: 50

Hellp Syndrome malady

Categories: Rare diseases, Reproductive diseases, Blood diseases, Cardiovascular diseases, Liver diseases

Aliases & Classifications for Hellp Syndrome

Aliases & Descriptions for Hellp Syndrome:

Name: Hellp Syndrome 12 50 56 52 42 14 69
Hemolysis, Elevated Liver Enzymes, Low Platelets in Pregnancy 56
Hemolysis-Elevated Liver Enzymes-Low Platelets Syndrome 56
Hemolysis, Elevated Liver Enzymes, Lowered Platelets 50

Classifications:



External Ids:

Disease Ontology 12 DOID:13133
ICD10 33 O14.2
MeSH 42 D017359
NCIt 47 C84750
SNOMED-CT 64 199010001 95605009
Orphanet 56 ORPHA244242
MESH via Orphanet 43 D017359
UMLS via Orphanet 70 C0162739
ICD10 via Orphanet 34 O14.2
UMLS 69 C0162739

Summaries for Hellp Syndrome

NIH Rare Diseases : 50 hellp syndrome is a life-threatening condition that can potentially complicate pregnancy. it is named for 3 features of the condition: hemolysis, elevated liver enzyme levels, and low platelet levels. it typically occurs in the last 3 months of pregnancy (the third trimester) but can also start soon after delivery. a wide range of non-specific symptoms may be present in women with hellp syndrome. symptoms may include fatigue; malaise; fluid retention and excess weight gain; headache; nausea and vomiting; pain in the upper right or middle of the abdomen; blurry vision; and rarely, nosebleed or seizures. the cause of hellp syndrome is not known, but certain risk factors have been associated with the condition. it is most common in women with preeclampsia or eclampsia. if not diagnosed and treated quickly, hellp syndrome can lead to serious complications for the mother and baby. the main treatment is to deliver the baby as soon as possible, even if premature. treatment may also include medications needed for the mother or baby, and blood transfusion for severe bleeding problems. last updated: 5/2/2016

MalaCards based summary : Hellp Syndrome, also known as hemolysis, elevated liver enzymes, low platelets in pregnancy, is related to hemolytic-uremic syndrome and ischemic optic neuropathy. An important gene associated with Hellp Syndrome is HELLPAR (HELLP Associated Long Non-Coding RNA), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Complement and coagulation cascades. The drugs Dexamethasone and Acetaminophen have been mentioned in the context of this disorder. Affiliated tissues include liver, endothelial and placenta, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A severe pre-eclampsia characterized by hemolysis, elevated liver enzyme and low platelet count.

Wikipedia : 71 HELLP syndrome is a life-threatening pregnancy complication usually considered to be a variant or... more...

Related Diseases for Hellp Syndrome

Diseases related to Hellp Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 222)
id Related Disease Score Top Affiliating Genes
1 hemolytic-uremic syndrome 30.1 F2 GPT SERPINC1
2 ischemic optic neuropathy 29.3 APOH F2 SERPINC1 SERPINE1 VWF
3 myocardial infarction 29.0 ADAMTS13 F2 F5 MTHFR PGF SERPINC1
4 preeclampsia/eclampsia 1 11.2
5 lchad deficiency 10.8
6 eclampsia 10.4
7 multiple familial trichoepithelioma 10.4 F5 MTHFR
8 congenital insensitivity to pain with severe intellectual disability 10.4 F2 F5
9 hepatitis 10.4
10 gastric neuroendocrine tumor type 1 10.4 GPT SLC17A5
11 photosensitive epilepsy 10.4 F2 F5 MTHFR
12 pancreatic ductal carcinoma 10.4 F2 F5 SERPINC1
13 female infertility of uterine origin 10.4 F2 GPT SLC17A5
14 houlston ironton temple syndrome 10.3 F2 F5 MTHFR
15 familial progressive hyperpigmentation 10.3 F2 GPT
16 mixed epithelial tumor of ovary 10.3 F2 MTHFR SERPINC1
17 kohler's disease 10.3 F2 GPT SLC17A5
18 pre-eclampsia 10.3
19 villous adenoma 10.3 F2 F5 MTHFR
20 myosclerosis, congenital 10.3 F5 MTHFR SERPINC1
21 scn8a-related epilepsy with encephalopathy 10.3 F2 MTHFR
22 eagle syndrome 10.3 F2 F5 SERPINC1
23 retinal arterial macroaneurysm with supravalvular pulmonic stenosis 10.3 F2 GPT SLC17A5
24 acute monocytic leukemia 10.3 F2 GPT SLC17A5
25 ductal carcinoma in situ 10.3 F2 MTHFR SERPINC1
26 med13l syndrome 10.3 APOH F5
27 alpha-2-plasmin inhibitor deficiency 10.3 F2 MTHFR SERPINC1
28 radiation induced cancer 10.3 GPT SLC17A5
29 capillary hemangioma 10.3 F2 MTHFR SERPINC1
30 gastrointestinal adenoma 10.3 F2 GPT HADHA
31 paranasal sinus sarcoma 10.3 F2 GPT SLC17A5
32 congenital hypoplastic anemia 10.3 F2 GPT SLC17A5
33 achard thiers syndrome 10.3 APOH F5
34 hendra virus infection 10.3 APOH F2 F5
35 vaginal discharge 10.3 F2 F5 MTHFR SERPINC1
36 alcoholic gastritis 10.3 F2 F5 MTHFR SERPINC1
37 lung cancer 10.3 APOH F5 MTHFR
38 childhood type dermatomyositis 10.3 F2 F5 MTHFR
39 hereditary alpha tryptasemia syndrome 10.3 F2 GPT SERPINC1 SLC17A5
40 cleft lip 10.3 F5 MTHFR SERPINC1
41 absence of innominate vein 10.3 F5 MTHFR SERPINE1
42 miller-dieker lissencephaly syndrome 10.3 F2 SERPINC1
43 aminoaciduria 10.3 F5 MTHFR SERPINE1
44 may-hegglin anomaly 10.3 APOH F2 SERPINC1
45 porphyria 10.3 F2 MTHFR
46 neuronopathy, distal hereditary motor, type iid 10.3 APOH F5 SERPINC1
47 stt3a-cdg and stt3b-cdg 10.3 F5 SERPINC1 SERPINE1
48 fletcher factor deficiency 10.3 F2 F5 VWF
49 noninfectious dermatoses of eyelid 10.3 F2 GPT SLC17A5
50 midline cystocele 10.3 F2 SERPINC1 SERPINE1

Graphical network of the top 20 diseases related to Hellp Syndrome:



Diseases related to Hellp Syndrome

Symptoms & Phenotypes for Hellp Syndrome

MGI Mouse Phenotypes related to Hellp Syndrome:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.06 VWF CD46 CFH F2 F5 FLT1
2 homeostasis/metabolism MP:0005376 10.03 ADAMTS13 APOH CFH CFI F2 F5
3 hematopoietic system MP:0005397 9.96 VWF HP SERPINC1 SERPINE1 ADAMTS13 CFH
4 mortality/aging MP:0010768 9.77 ADAMTS13 APOH CFH F2 F5 FLT1
5 vision/eye MP:0005391 9.23 ADAMTS13 CD46 CFH FLT1 MTHFR PGF

Drugs & Therapeutics for Hellp Syndrome

Drugs for Hellp Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 87)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3 50-02-2 5743
2
Acetaminophen Approved Phase 4 103-90-2 1983
3
Ibuprofen Approved Phase 4 15687-27-1 3672
4
Magnesium Sulfate Approved, Vet_approved Phase 4,Phase 2,Phase 3 7487-88-9 24083
5
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 3 67-97-0 6221 10883523 5280795
6
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3 50-14-6 5280793
7 Anti-Inflammatory Agents Phase 4,Phase 3
8 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
9 Calcium, Dietary Phase 4,Phase 3,Phase 2
10 Antiemetics Phase 4,Phase 3
11 Antineoplastic Agents, Hormonal Phase 4,Phase 3
12 Autonomic Agents Phase 4,Phase 3,Phase 2
13 BB 1101 Phase 4,Phase 3
14 Dexamethasone 21-phosphate Phase 4,Phase 3
15 Dexamethasone acetate Phase 4,Phase 3 1177-87-3
16 Gastrointestinal Agents Phase 4,Phase 3
17 glucocorticoids Phase 4,Phase 3
18 HIV Protease Inhibitors Phase 4,Phase 3
19 Hormone Antagonists Phase 4,Phase 3
20 Hormones Phase 4,Phase 3
21 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
22
protease inhibitors Phase 4,Phase 3
23 Analgesics Phase 4,Phase 3,Phase 2
24 Analgesics, Non-Narcotic Phase 4,Phase 3
25 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3
26 Antipyretics Phase 4,Phase 3
27 Antirheumatic Agents Phase 4,Phase 3
28 Cyclooxygenase Inhibitors Phase 4,Phase 3
29 Bone Density Conservation Agents Phase 4,Phase 3
30 Micronutrients Phase 4,Phase 3
31 Trace Elements Phase 4,Phase 3
32 Vitamins Phase 4,Phase 3
33 Pharmaceutical Solutions Phase 4,Phase 3
34 Anesthetics Phase 4,Phase 3,Phase 2
35 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3
36 Anticonvulsants Phase 4,Phase 2,Phase 3
37 calcium channel blockers Phase 4,Phase 2,Phase 3
38 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
39 Tocolytic Agents Phase 4,Phase 2,Phase 3
40 Ergocalciferols Phase 4,Phase 3
41 vitamin d Phase 4,Phase 3
42 Calciferol Nutraceutical Phase 4,Phase 3
43 Vitamin D2 Nutraceutical Phase 4,Phase 3
44
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
45
Dalteparin Approved Phase 3 9041-08-1
46
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
47
Vitamin C Approved, Nutraceutical Phase 3 50-81-7 5785 54670067
48
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
49 Antioxidants Phase 3
50 Protective Agents Phase 3

Interventional clinical trials:

(show all 27)
id Name Status NCT ID Phase
1 Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features Recruiting NCT02911701 Phase 4
2 Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia Recruiting NCT03164304 Phase 4
3 A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Recruiting NCT02920593 Phase 4
4 Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome Active, not recruiting NCT00711841 Phase 4
5 Dexamethasone Efficacy in HELLP I Syndrome Unknown status NCT01138839 Phase 3
6 Calcium for Pre-Eclampsia Prevention (CPEP) Completed NCT00000534 Phase 3
7 RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil Completed NCT00097110 Phase 3
8 Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia Completed NCT00986765 Phase 3
9 The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction) Recruiting NCT02277132 Phase 2, Phase 3
10 Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART) Active, not recruiting NCT00920621 Phase 3
11 Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean Withdrawn NCT01451060 Phase 3
12 Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial Withdrawn NCT00293735 Phase 2, Phase 3
13 Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia Terminated NCT02286284 Phase 2
14 A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot Study Unknown status NCT02527018 Phase 1
15 The SMART-ORACLE Study Unknown status NCT01932671
16 Platelet Count Trends in Pre-eclamptic Parturients Completed NCT00787241
17 A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk Completed NCT00572793
18 Doppler and Biological Second Trimester Placental Insufficiency Screening Completed NCT00465634
19 Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, Superimposed Preeclampsia or HELLP-syndrome Recruiting NCT02754778
20 The Preeclampsia Registry Recruiting NCT02020174
21 Women Specific Cardiac Recovery After Preeclampsia Recruiting NCT02807324
22 Pancreatic Stone Protein (PSP) in Pregnant Women Recruiting NCT02247297
23 PC Protocol: Preconceptional Screening Recruiting NCT02309073
24 Free DNA and Nucleosome Concentrations in Pathological Pregnancies Recruiting NCT01736826
25 PREPARE, Prematurity Reduction by Pre-eclampsia Care Recruiting NCT03073317
26 General Anesthesia Versus Spinal Anesthesia in Patients of HELLP Syndrome Not yet recruiting NCT03111446
27 A Lifestyle Intervention to Improve in Vitro Fertilization Results Not yet recruiting NCT02648555

Search NIH Clinical Center for Hellp Syndrome

Cochrane evidence based reviews: hellp syndrome

Genetic Tests for Hellp Syndrome

Anatomical Context for Hellp Syndrome

MalaCards organs/tissues related to Hellp Syndrome:

39
Liver, Endothelial, Placenta, Testes, Brain, Kidney, Bone

Publications for Hellp Syndrome

Articles related to Hellp Syndrome:

(show top 50) (show all 605)
id Title Authors Year
1
HELLP syndrome in a pregnant patient with Gitelman syndrome. ( 28393002 )
2017
2
SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY EVALUATION OF CHORIORETINAL CHANGES IN HYPERTENSIVE CHOROIDOPATHY RELATED TO HELLP SYNDROME. ( 28067720 )
2017
3
Diagnosis and Management of HELLP Syndrome Complicated by Liver Hematoma. ( 28005587 )
2017
4
Maternal endothelial function and vascular stiffness after HELLP syndrome: a case-control study. ( 28004456 )
2016
5
Anesthetic practices for patients with preeclampsia or HELLP syndrome: A survey. ( 27651719 )
2016
6
Hepatic Artery Embolization for Hepatic Rupture in HELLP Syndrome. ( 27886958 )
2016
7
Postpartum high fever and imitators of HELLP syndrome. ( 27590211 )
2016
8
Resolution of HELLP syndrome after selective feticide for trisomy 21 in discordant twins - A case report. ( 26804722 )
2016
9
Elevated systemic galectin-1 levels characterize HELLP syndrome. ( 26956510 )
2016
10
HELLP syndrome: a diagnostic conundrum with severe complications. ( 27535735 )
2016
11
Scrub typhus masquerading as HELLP syndrome and puerperal sepsis in an asymptomatic malaria patient. ( 27413718 )
2016
12
Transfusion Related Acute Lung Injury after Cesarean Section in a Patient with HELLP Syndrome. ( 26885326 )
2016
13
Pre- and intraretinal haemorrhages in a 22-week-old fetus of a mother suffering from HELLP syndrome and factor V Leiden mutation with deep vein thrombosis. ( 27229627 )
2016
14
Maternal cardiac function after HELLP syndrome: an echocardiographic study. ( 27854396 )
2016
15
Author's reply re: Microcirculation in women with severe pre-eclampsia and HELLP syndrome: a case control study. ( 27531337 )
2016
16
Anesthesia in pregnant women with HELLP syndrome: case report. ( 27793243 )
2016
17
Re: Microcirculation in women with severe pre-eclampsia and HELLP syndrome: a case control study: Effect of timing of extracorporeal membrane oxygenation during HELLP syndrome. ( 27531338 )
2016
18
A Hat-Trick Knock-Reversible Triple Organ Injury in a New Mother With HELLP Syndrome. ( 27755233 )
2016
19
Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know? ( 27181089 )
2016
20
A HELLP syndrome complicates a gestational trophoblastic neoplasia in a perimenopausal woman: a case report. ( 27485461 )
2016
21
Reply: Postpartum high fever and imitators of HELLP syndrome. ( 27592726 )
2016
22
No Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for All. ( 27222631 )
2016
23
Late postpartum HELLP syndrome over 10 days after delivery. ( 27260549 )
2016
24
HELLP Syndrome: Altered Hypoxic Response of the Fatty Acid Oxidation Regulator SIRT 4. ( 27651178 )
2016
25
Direct evidence of complement activation in HELLP syndrome: A link toA atypical hemolytic uremic syndrome. ( 26921648 )
2016
26
Maternal-fetal prognosis in HELLP syndrome in a level 3 maternal-fetal care centre. ( 27328494 )
2016
27
Postpartum corticosteroids in HELLP syndrome - standard to prompt recovery. ( 27546544 )
2016
28
A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome. ( 27028698 )
2016
29
Brain abscess due to Listeria monocytogenes after HELLP syndrome in a patient with antiphospholipid syndrome. ( 27927881 )
2016
30
Are there any additional mechanisms for haemolysis in HELLP syndrome? ( 27128171 )
2016
31
CHOROIDAL MORPHOLOGY IN A PATIENT WITH HELLP SYNDROME. ( 26595148 )
2016
32
The placental component and obstetric outcome in severe preeclampsia with and without HELLP syndrome. ( 27780546 )
2016
33
Maternal and fetal parameters including umbilical artery PI and fibrinogen/CRP ratio as predictive factors of perinatal outcome in women with HELLP syndrome. ( 25920306 )
2015
34
[5-OR]: Transient elastography (TE) of the liver as a new diagnostic tool to discriminate between HELLP syndrome and acute fatty liver of pregnancy (AFLP)? ( 25787354 )
2015
35
Management of Spontaneous Hepatic Rupture on Top of HELLP Syndrome: Case Report and Review of the Literature. ( 26468317 )
2015
36
Revisiting HELLP syndrome. ( 26525965 )
2015
37
Hypertension-Management of Hypertensive Disorders of Pregnancy According to International Guidelines: A Panel Discussion (Case 4: HELLP Syndrome). ( 26030817 )
2015
38
HELLP Syndrome and the Effects on the Neonate. ( 26802826 )
2015
39
Differentiation of ICOS(+) and ICOS(-) recent thymic emigrant regulatory T cells (RTE Tregs ) during normal pregnancy, pre-eclampsia and HELLP syndrome. ( 26285098 )
2015
40
Corticosteroid Therapy for Management of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis. ( 26633822 )
2015
41
HELLP Syndrome. How to recognize and treat this life-threatening complication of pregnancy. ( 26146751 )
2015
42
Pulmonary embolism in the setting of HELLP syndrome. ( 25794414 )
2015
43
Early identification of women with HELLP syndrome who need plasma exchange after delivery. ( 25571785 )
2015
44
Severe ascites as the primary symptom of fulminant postpartum HELLP syndrome: a case report. ( 26524826 )
2015
45
Effects of serum from patients with early-onset pre-eclampsia, HELLP syndrome, and antiphospholipid syndrome on fatty acid oxidation in trophoblast cells. ( 25740297 )
2015
46
Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America. ( 25687238 )
2015
47
Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1. ( 26130680 )
2015
48
Anesthetic considerations in HELLP syndrome. ( 26446688 )
2015
49
First trimester prediction of HELLP Syndrome. ( 26402854 )
2015
50
[228-POS]: A complicated pregnancy with preeclampsia, HELLP syndrome, and thrombotic microangiopathy in a woman with lupus and antiphospholipid syndrome. ( 25787579 )
2015

Variations for Hellp Syndrome

Expression for Hellp Syndrome

Search GEO for disease gene expression data for Hellp Syndrome.

Pathways for Hellp Syndrome

GO Terms for Hellp Syndrome

Cellular components related to Hellp Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.9 APOH CD46 CFH CFI F2 GPT
2 extracellular region GO:0005576 9.77 ADAMTS13 APOH CFH CFI F2 F5
3 endoplasmic reticulum lumen GO:0005788 9.71 ADAMTS13 F2 F5 SERPINC1
4 blood microparticle GO:0072562 9.56 CFH F2 HP SERPINC1
5 platelet alpha granule lumen GO:0031093 9.5 F5 SERPINE1 VWF
6 extracellular space GO:0005615 9.44 ADAMTS13 APOH CFH CFI F2 F5
7 platelet alpha granule GO:0031091 9.37 F5 VWF

Biological processes related to Hellp Syndrome according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 proteolysis GO:0006508 9.95 ADAMTS13 CD46 CFI F2 F5 HP
2 platelet degranulation GO:0002576 9.76 APOH F5 SERPINE1 VWF
3 platelet activation GO:0030168 9.73 ADAMTS13 F2 F5 VWF
4 blood coagulation GO:0007596 9.72 ADAMTS13 F2 F5 SERPINC1 VWF
5 regulation of complement activation GO:0030449 9.71 CD46 CFH CFI F2
6 regulation of blood coagulation GO:0030193 9.54 APOH F2 SERPINC1
7 negative regulation of blood coagulation GO:0030195 9.49 APOH SERPINE1
8 blood coagulation, intrinsic pathway GO:0007597 9.43 APOH F2 VWF
9 positive regulation of blood coagulation GO:0030194 9.33 APOH F2 SERPINE1
10 negative regulation of fibrinolysis GO:0051918 9.13 APOH F2 SERPINE1
11 hemostasis GO:0007599 9.02 ADAMTS13 F2 F5 SERPINC1 VWF

Molecular functions related to Hellp Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 9.33 SERPINC1 SERPINE1 VWF
2 serine-type endopeptidase activity GO:0004252 9.26 CFI F2 F5 HP
3 heparin binding GO:0008201 9.02 APOH CFH F2 PGF SERPINC1

Sources for Hellp Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....